Does economics matter when treating advanced non-small cell lung cancer?
Ramsey
Scott D
SD
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. sramsey@fhcrc.org
Kessler
Larry G
LG
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000191:economics* / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage / Q000191:economics; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D007348:Insurance, Health; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000191:economics*; D008495:Medical Oncology / Q000639:trends; D015337:Multicenter Studies as Topic; D017239:Paclitaxel / Q000008:administration & dosage / Q000191:economics
D016190:Carboplatin; D017239:Paclitaxel